1396772-45-4

Basic information

• Product Name: N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-1-isopropyl-6-(4-(morpholinomethyl)phenyl)-1H-indazole-4-carboxamide
• Synonyms: N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-1-isopropyl-6-(4-(morpholinomethyl)phenyl)-1H-indazole-4-carboxamide
• CAS NO: 1396772-45-4
• Molecular Weight: 513.64
• Mol File: 1396772-45-4.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-1-isopropyl-6-(4-(morpholinomethyl)phenyl)-1H-indazole-4-carboxamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-1-isopropyl-6-(4-(morpholinomethyl)phenyl)-1H-indazole-4-carboxamide(1396772-45-4)
• EPA Substance Registry System: N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-1-isopropyl-6-(4-(morpholinomethyl)phenyl)-1H-indazole-4-carboxamide(1396772-45-4)

Safety Data

• Hazardous Substances Data: 1396772-45-4(Hazardous Substances Data)

Upstream product

• 1346597-55-4 methyl 1-acetyl-6-bromo-1H-indazole-4-carboxylate 
• 1000342-11-9 2-methyl-3-amino-5-bromobenzoic acid methyl ester 
• 1346702-52-0 methyl 6-bromo-1-(1-methylethyl)-1H-indazole-4-carboxylate 
• 771579-27-2 3-(aminomethyl)-4,6-dimethyl-1,2-dihydropyridin-2-one 
• 1346702-54-2 6-bromo-1-(1-methylethyl)-1H-indazole-4-carboxylic acid 
• 885518-49-0 methyl 6-bromo-1H-indazole-4-carboxylate 
• 1975-50-4 2-methyl-3-nitrobenzic acid 
• 220514-28-3 5-bromo-2-methyl-3-nitrobenzoic acid methyl ester 
• 107650-20-4 5-bromo-2-methyl-3-nitro-benzoic acid 
• 1346702-51-9 6-bromo-N-[(4,6-dimethyl-2-oxo-1,2-dihydro-3-pyridinyl)methyl]-1-(1-methylethyl)-1H-indazole-4-carboxamide 
• 364794-79-6 4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl]morpholine 

Relevant articles and documents

SUBSTITUTED 6,5-FUSED BICYCLIC HETEROARYL COMPOUNDS

The present invention relates to substituted 6,5 -fused bicyclic heteroaryl compounds. The present invention also relates to pharmaceutical compositions containing these compounds and methods of treating cancer by administering these compounds and pharmaceutical compositions to subjects in need thereof.